TaqMan assay for Swedish Chlamydia trachomatis variant [7]

Emerging Infectious Diseases

Volumn 13, Issue 9, 2007, Pages 1432-1434

  Catsburg, Arnold ^a   Van Dommelen, Laura ^b   Smelov, Vitaly ^c,d   De Vries, Henry J C ^e,f   Savitcheva, Alevtina ^c   Domeika, Marius ^g   Herrmann, Björn ^h   Ouburg, Sander ^a   Hoebe, Christian J P A ⁱ   Nilsson, Anders ^h   Savelkoul, Paul H M ^a   Morre, Servaas A ^a,b,j  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

^d ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^e Amsterdam Health Service   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UPPSALA UNIVERSITY   (Sweden)

^h UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁱ South Limburg Public Health Service   (Netherlands)

^j CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL STRAIN; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DNA EXTRACTION; FALSE NEGATIVE RESULT; GENE DELETION; GENE SEQUENCE; HUMAN; LETTER; NONHUMAN; NUCLEIC ACID AMPLIFICATION TEST; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SWEDEN; TISSUE CULTURE; UTERINE CERVIX SWAB;

EID: 34848912063     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1309.070263     Document Type: Letter

References (10)

1. Soderblom T, Blaxhult A, Fredlund H, Herrmann B. Impact of a genetic variant of Chlamydia trachomatis on national detection rates in Sweden. Euro Surveill. 2006;11:E061207.1.
2. de Vries HJC, Catsburg A, van der Helm JJ, Beukelaar EC, Morré SA, Fennema JSA, et al. No indication of Swedish Chlamydia trachomatis variant among STI clinic visitors in Amsterdam. Euro Surveill. 2007;12:E070208.3.
3. Lynagh Y, Crowley B, Walsh A. Investigation to determine if newly-discovered variant of Chlamydia trachomatis is present in Ireland. Euro Surveill. 2007;12:E070201.2.
4. Moghaddam A, Reinton N. Identification of the Swedish Chlamydia trachomatis variant among patients attending a STI clinic in Oslo, Norway. Euro Surveill. 2007;12:E070301.3.
5. de Laar V, Ison C. Europe-wide investigation to assess the presence of new variant of Chlamydia trachomatis in Europe. Euro Surveill. 2007;12:E070208.4.
6. Ripa T, Nilsson PA. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis. 2007;34:255-6.
7. Catsburg A, van der Zwet WC, Morré SA, Ouburg S, Vandenbroucke-Grauls CM, Savelkoul PH. Analysis of multiple single nucleotide polymorphisms (SNP) on DNA traces from plasma and dried blood samples. J Immunol Methods. 2007;321:135-41.
8. Savitcheva A, Smirnova T, Pavlova N, Bashmakova M, Shishkina O, Novikov B, et al. Diagnosis and treatment of genital Chlamydia trachomatis infection in St. Petersburg and Leningradskaya Oblastj. In: Domeika M., Hallen A., editors. Chlamydia trachomatis infection in Eastern Europe. Uppsala (Sweden): Uppsala University; 2000.
9. Morré SA, Sillekens P, Jacobs MV, van Aarle P, de Blok S, van Gemen B, et al. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol. 1996;34:3108-14.
10. Morré SA, Spaargaren J, Fennema JSA, de Vries HJC, Peña AS. Real-time PCR for the rapid one-step diagnosis of Chlamydia trachomatis LGV infection to help manage and contain the current outbreak in Europe and the USA. Emerg Infect Dis. 2005;11:1311-2 1434-1436